Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 21, 2025 06:49 ET | Source: Research and Markets

Gastric Neuroendocrine Tumors Market Report 2025 | Advancements in Diagnostics Propel Early Detection of gNETs

Dublin, April 21, 2025 (GLOBE NEWSWIRE) -- The "Gastric Neuroendocrine Tumors Market" report has been added to ResearchAndMarkets.com's offering. The gastric neuroendocrine tumor (gNET) market,...
October 01, 2024 06:48 ET | Source: Research and Markets

Neuroendocrine Tumors (NETs) Market Research 2024-2030 with Analyst Recommendations - Establishment of Specialist Therapeutic Centers / Organize Campaigns to Raise Awareness

Dublin, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The "Global Neuroendocrine Tumors (NETs) Market (2024 Edition): Analysis By Therapy (Somatostatin Analogs (SSAs), Targeted Therapy, Others), By Route of...
July 17, 2024 10:15 ET | Source: Research and Markets

Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) Pipeline Analysis 2024

Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's...
January 23, 2024 02:43 ET | Source: Research and Markets

Neuroendocrine Tumor Treatment Market Set to Surge with Innovative Therapies and Global Expansion

Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Neuroendocrine Tumor Treatment Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The neuroendocrine tumor...
March 28, 2023 09:13 ET | Source: Research and Markets

Neuroendocrine Tumor Treatment Global Market Report 2023: Developments and Approval of Novel Drugs to Boost Growth

Dublin, March 28, 2023 (GLOBE NEWSWIRE) -- The "Neuroendocrine Tumor Treatment Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028 Segmented By Product...
June 15, 2022 08:18 ET | Source: Research and Markets

Global mTOR (Mammalian Target of Rapamycin) Inhibitors Markets, 2022-2030 with 2021 as the Base Year - Increasing Product Approvals from Regulatory Bodies is Expected to Drive Growth

Dublin, June 15, 2022 (GLOBE NEWSWIRE) -- The "mTOR Inhibitors Market, by Drug Type, By Indication, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and...
October 14, 2021 07:13 ET | Source: Research and Markets

Global Neuroendocrine Tumors Market & Drug Forecast 2021-2030 | Most Important Unmet Needs and the Projected Impact of 5 Late-Stage Pipeline Agents Entering the Market

Dublin, Oct. 14, 2021 (GLOBE NEWSWIRE) -- The "Neuroendocrine Tumors - Global Drug Forecast and Market Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. The market of...
March 04, 2021 06:48 ET | Source: Research and Markets

Global Neuroendocrine Tumors (NET) Market Spotlight 2020-2028

Dublin, March 04, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Neuroendocrine tumors (NET)" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the...
October 27, 2017 05:01 ET | Source: Future Market Insights Global and Consulting Pvt. Ltd.

Global Neuroendocrine Carcinoma Market to Generate US$ 2.5 Bn by 2027 End – Future Market Insights

Valley Cottage, New York, Oct. 27, 2017 (GLOBE NEWSWIRE) -- Recently, FMI has presented value analysis and insights on the various disease types, treatment types and end users associated with the...